- The role of glia in protein aggregation.
- Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance.
- Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East.
- Neurodegenerative disease-associated protein aggregates are poor inducers of the heat shock response in neuronal cells.
- A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders.
- Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis.
- AAV5-miHTT gene therapy for Huntington disease: lowering both huntingtins.
- Therapeutic strategies for Huntington's disease.
- Therapeutic antisense oligonucleotides for movement disorders.
- Three-dimensional chromatin interactions remain stable upon CAG/CTG repeat expansion.
- Huntingtin gene CAG repeat size affects autism risk: Family-based and case-control association study.
- Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates.
- Differential expression of skeletal muscle mitochondrial proteins in yak, dzo, and cattle: a proteomics-based study.
- Clinical, radiological, and genetic characteristics in patients with Huntington's disease in a Taiwanese cohort.
- Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.
- Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington's disease.
- Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
- A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models.
- Transcriptional dysregulation in Huntington's Disease. The role in pathogenesis and potency for pharmacological targeting.
- Peptidyl inhibition of Spt4-Spt5: Protein-protein inhibitors for targeting the transcriptional pathway related to C9orf72 expansion repeats.
- Strategies for the molecular imaging of amyloid and the value of multi-modal approach.
- Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease.
- Compromised IGF signaling causes caspase-6 activation in Huntington disease.
- Cognition, function and awareness of disease impact in early Parkinson's and Huntington's disease.
- Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.
- Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington's disease.
- Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
- Flexible Non-Negative Matrix Factorization to Unravel Disease-Related Genes.
- A Systematic Review of Minor Phytocannabinoids with Promising Neuroprotective Potential.
- Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.
- Striatal connectivity in premanifest Huntington disease is differentially affected by disease burden.
- Protofilament structure and supramolecular polymorphism of aggregated mutant huntingtin exon 1.
- Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.
- Strategies to Investigate Ubiquitination in Huntington's Disease.
- A feasibility investigation of mindfulness-based cognitive therapy for people with Huntington's disease.
- Huntingtons disease: A new evidence of neurovascular dysfunction.
- The contribution of glial cells to Huntington's disease pathogenesis.
- The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation.
- MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes.
- Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease.
- Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects.
- Kinetics of Fast Tetramerization of the Huntingtin Exon 1 Protein Probed by Concentration-Dependent On-Resonance R1ρ Measurements.
- Do patients diagnosed with a neurological disease present increased risk of suicide?
- Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.
- Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
- Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases.
- Huntingtin-Associated Protein 1 in Mouse Hypothalamus Stabilizes Glucocorticoid Receptor in Stress Response.
- Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.
- Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease.
- Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease.
RSS Feed – Literature
HDinHD > RSS Feed – Literature
